Tarsus Pharmaceuticals, Inc.

TARS - CIK 0001819790

Market cap$2.64 B

Rank#1904

SEC filings617

TARS balance sheet (annual)

The table below shows Tarsus Pharmaceuticals, Inc.'s balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.

Line item	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Cash & equivalents	$183.64M	$94.82M	$224.95M	$71.66M	$171.33M	$168.13M
Short-term investments	$233.63M	$196.56M	$2.50M	$145.37M	$483.00K	-
Receivables	$85.06M	$46.76M	$16.62M	-	-	-
Inventory	$4.37M	$2.62M	$3.11M	-	-	-

Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.